Results 191 to 200 of about 3,904 (202)

Extended-Release Calcifediol (ERC) for Secondary Hyperparathyroidism (SHPT) in Chinese Patients with Stages 3 and 4 CKD: A Phase 3 Trial

Journal of the American Society of Nephrology
M. Fang, Haoyan Haoyan, Huijuan Mao, Hong Ren, H. Lin, Haiming Li   +5 more
semanticscholar   +1 more source

Calcifediol/calcium/teriparatide

Reactions Weekly, 2017
openaire   +1 more source

Calcifediol/calcitriol/colecalciferol

Reactions Weekly, 2018
openaire   +1 more source

Calcifediol as a therapeutic

John S. Adams, Albert Shieh, Charles W. Bishop   +2 more
openaire   +1 more source

Impact of BMI on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D with calcifediol supplementation in young adults: a longitudinal study

Endocrine
L. Das, N. Sachdeva, M. Holick, M. Devnani, Pinaki Dutta, R. Marwaha   +5 more
semanticscholar   +1 more source

Effect of cholecalciferol versus calcifediol on serum 25(OH)D concentrations: a systematic review with meta-analysis

European Journal of Clinical Nutrition
Selma Bouden, Meriam Ben Messaoud, O. Saidane, L. Rouached, A. Ben Tekaya, Ines Mahmoud, R. Tekaya, Chedly Dziri, L. Abdelmoula   +8 more
semanticscholar   +1 more source

Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease

Expert Review of Endocrinology and Metabolism, 2017
Stuart M Sprague, Stephen A Strugnell, Charles W Bishop   +2 more
exaly  

Calcifediol for renal osteodystrophy.

The Medical letter on drugs and therapeutics, 1982
openaire   +1 more source

Extended-Release Calcifediol in Renal Disease

2018
Martin Petkovich, Charles W. Bishop
openaire   +1 more source

POTENTIAL USE FOR CALCIFEDIOL IN RENAL OSTEODYSTROPHY

InPharma, 1976
openaire   +1 more source